About us
Profile
Contributors
Staff
Address
Contact Us
Articles
Canada
USA
International
Topics
Access to Medicines
Innovation
Comparative Effectiveness
Health Technology Assessment
Importation
Global Public Health
Emerging Markets
Patient Safety
Patient Advocacy
Events
Publications
Presentations
Reports and Research Papers
Register
Home
|
Topics
| Health Technology Assessment
patient safety
1.
At least Two-Thirds of Foreign Drug Manufacturers that Export to the U.S. Have Never Been Inspected by the FDA
2.
Sales of Imported Drugs Drop 80 Percent as Americans Abandon Risky Drug Importation
3.
As lawmakers consider making it easier to import foreign drugs nearly two-thirds of Americans lack confidence in foreign manufactured prescription drugs
4.
Encouraging consumers to import foreign drugs puts american patients at risk
5.
Despite significant increases in drug utilization, hospitalizations for adverse effects have declined in Canada
6.
Counterfeit medicines threaten public health in Peru
7.
WHO’s South East Asian Region (SEAR) May Not See Eye to Eye with WHO & EU on IP Rights
8.
Slower drug approval times do not improve patient safety
9.
H.H.S. report on drug importation concludes that there are significant risks associated with importing drugs for personal use
10.
State-sanctioned drug importation websites demonstrate problems regulating quality, safety and patient privacy standards of foreign pharmacies
<<
Start
<
Prev
1
2
Next
>
End
>>
Powered by
Tags for Joomla
Top Topics
access to medicines
canada
chronic disease
disease management
global health
health policy
health spending
innovation
usa
world health organization
Latest News
Social media is changing how epidemiologists discover and track disease outbreaks
CBO report: further restricting DTC advertising may be bad for public health
UN hosts interactive hearing on NCDs
Social media can greatly enhance the effectiveness of traditional marketing
64th World Health Assembly – resolutions and highlights
Popular Articles
Chronic Disease highlighted at World Economic Forum 2011
Pharmacy reform in Ontario to address overpriced generic medicines
Global partnerships facilitate access to medicines
Treatment of rare disorders: U.S and Europe enact legislation to encourage innovation and access while Canada lags behind
Accessing Drugs for Rare Diseases in Canada: The Patient Perspective
Social Media
Login
Username:
Password:
Remember Me
Forgot your password?
Forgot your username?
Create an account
Who's Online
We have
163 guests
online
Latest Events
No events
copyright © World Health Advocacy Inc.